Understanding of recent legal developments can help companies avoid infringement.
Drew Hillier
Advertisement
Associate at Buchanan Ingersoll & Rooney
Articles by Drew Hillier
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
WHO Finalizes United States’ Withdrawal from Organization: Report
2
JP Morgan 2026 Wrap Up: Pharma Leaders Speak About the Conference and the State of the Industry
3
Janux Therapeutics Enters $850 Million Collaboration and Exclusive License Agreement with Bristol Myers Squibb to Develop Tumor-Activated Therapeutics
4
What is Daiichi Sankyo’s Post JP Morgan Strategy?
5